RRC ID 35697
著者 Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T.
タイトル Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers.
ジャーナル Cancer Cell
Abstract Constitutive NF-κB activation has causative roles in adult T cell leukemia (ATL) caused by HTLV-1 and other cancers. Here, we report a pathway involving Polycomb-mediated miRNA silencing and NF-κB activation. We determine the miRNA signatures and reveal miR-31 loss in primary ATL cells. MiR-31 negatively regulates the noncanonical NF-κB pathway by targeting NF-κB inducing kinase (NIK). Loss of miR-31 therefore triggers oncogenic signaling. In ATL cells, miR-31 level is epigenetically regulated, and aberrant upregulation of Polycomb proteins contribute to miR-31 downregulation in an epigenetic fashion, leading to activation of NF-κB and apoptosis resistance. Furthermore, this emerging circuit operates in other cancers and receptor-initiated NF-κB cascade. Our findings provide a perspective involving the epigenetic program, inflammatory responses, and oncogenic signaling.
巻・号 21(1)
ページ 121-35
公開日 2012-1-17
DOI 10.1016/j.ccr.2011.12.015
PII S1535-6108(11)00477-6
PMID 22264793
MeSH Epigenesis, Genetic Gene Expression Profiling Gene Expression Regulation, Neoplastic* Humans Leukemia-Lymphoma, Adult T-Cell / genetics* Leukemia-Lymphoma, Adult T-Cell / metabolism MicroRNAs / genetics* NF-kappa B / genetics NF-kappa B / metabolism* Oligonucleotide Array Sequence Analysis Polycomb-Group Proteins Protein Serine-Threonine Kinases / metabolism Protein Serine-Threonine Kinases / physiology* Repressor Proteins / genetics* Repressor Proteins / metabolism Repressor Proteins / physiology Signal Transduction T-Lymphocytes / metabolism T-Lymphocytes / pathology*
IF 26.602
引用数 198
WOS 分野 ONCOLOGY CELL BIOLOGY
リソース情報
遺伝子材料 CS-RfA-EVBsd (RDB06090) pENTR4-H1 (RDB04395) pCAG-HIVgp (RDB04394) pCMV-VSV-G-RSV-Rev (RDB04393).